Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03620071 · ClinicalTrials.gov registry record · NA

GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
67
Enrollment target

NCT03620071: Completed NA study, sponsored by Stanford University.

NCT03620071 is a NA study that has completed, run by Stanford University. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03620071, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target

Study Summary

This proposal addresses the major challenge of improving health outcomes for children with cancer and other complex conditions, for whom the effectiveness of outpatient care depends on care coordination across a diverse group of caregivers that includes parents, community support organizations and pediatric care providers. The investigators have developed GoalKeeper, a prototype system for supporting care coordination across multiple care providers. The primary aim of the clinical trial is to assess the potential for this new system, GoalKeeper, to improve meaningful use of goal-centered care plans in the care of children with cancer and other complex chronic conditions.

Primary Outcome

Parent perception of goal-centered care will be measured using a modified version of the "Patient Assessment of Chronic Illness Care, Goal-Setting Domain" questionnaire, using a scale of 1(Almost Never) to 5 (Almost Always) with higher values representing better goal-centered care.

Interventions

  • OTHER Standard Care
  • OTHER GoalKeeper

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2019-04-19
Est. Completion 2021-03-17
Phase NA
Stanford University

1,744 total trials

What the finished NCT03620071 record still lists

NCT03620071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.

NCT03620071 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03620071 about?

NCT03620071 is a clinical study titled "GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity". This proposal addresses the major challenge of improving health outcomes for children with cancer and other complex conditions, for whom the effectiveness of outpatient care depends on care coordination across a diverse group of caregivers that includes parents, community support organizations and p...

What is the current status of trial NCT03620071?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-04-19. Estimated completion is 2021-03-17.

What interventions are being tested in trial NCT03620071?

The interventions under investigation include: Standard Care (OTHER), GoalKeeper (OTHER).

Who is sponsoring clinical trial NCT03620071?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03620071's enrollment target sits among peer trials

67 1139th of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03620071, the US trial registry maintained by the National Library of Medicine. NCT03620071 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.